ZA7671B - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
ZA7671B
ZA7671B ZA760071A ZA7671A ZA7671B ZA 7671 B ZA7671 B ZA 7671B ZA 760071 A ZA760071 A ZA 760071A ZA 7671 A ZA7671 A ZA 7671A ZA 7671 B ZA7671 B ZA 7671B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
ZA760071A
Other languages
English (en)
Inventor
B Poulsen
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of ZA7671B publication Critical patent/ZA7671B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Paper (AREA)
ZA760071A 1975-02-21 1976-01-06 Pharmaceutical composition ZA7671B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/551,811 US3934013A (en) 1975-02-21 1975-02-21 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
ZA7671B true ZA7671B (en) 1977-08-31

Family

ID=24202770

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA760071A ZA7671B (en) 1975-02-21 1976-01-06 Pharmaceutical composition

Country Status (18)

Country Link
US (1) US3934013A (tr)
JP (1) JPS6135166B2 (tr)
AU (1) AU504748B2 (tr)
BE (1) BE838711A (tr)
BR (1) BR7600834A (tr)
CA (1) CA1067409A (tr)
DE (1) DE2605242A1 (tr)
DK (1) DK68876A (tr)
ES (1) ES445151A1 (tr)
FI (1) FI67415C (tr)
FR (1) FR2301262A1 (tr)
GB (1) GB1502544A (tr)
IE (1) IE43655B1 (tr)
IL (1) IL48797A (tr)
IT (1) IT1066085B (tr)
NL (1) NL7601667A (tr)
NZ (1) NZ180042A (tr)
ZA (1) ZA7671B (tr)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX3864E (es) 1975-05-27 1981-08-26 Syntex Corp Un proceso para prepara el compuesto cristalino 6-fluiro-11b 21-dihiroxi-16 17-isopropilidendioxipregna-1 4-dien-3 20-diona
US4070462A (en) * 1976-10-26 1978-01-24 Schering Corporation Steroid ointment
IL53617A0 (en) * 1976-12-17 1978-03-10 Scherico Ltd Improvements in or relating to antibiotic formulations
KR830005852A (ko) * 1980-07-18 1983-09-14 미첼 페터 잭슨 피부와 점막의 비루스 감염치료에 적합한 국소치료제의 제조방법
GB2080106B (en) * 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations
US4304765A (en) * 1980-10-14 1981-12-08 Alza Corporation Ocular insert housing steroid in two different therapeutic forms
US4432964A (en) * 1981-08-24 1984-02-21 Alza Corporation Topical composition containing steroid in two forms released independently from polymeric carrier
US4478818A (en) * 1982-12-27 1984-10-23 Alza Corporation Ocular preparation housing steroid in two different therapeutic forms
US4489070A (en) * 1983-05-13 1984-12-18 Schering Corporation Betamethasone dipropionate cream
US4482539A (en) * 1983-05-13 1984-11-13 Schering Corporation Betamethasone dipropionate cream
US4537776A (en) * 1983-06-21 1985-08-27 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone
US4552872A (en) * 1983-06-21 1985-11-12 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing corticosteroids
US4557934A (en) * 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
EP0196121A1 (en) * 1985-02-22 1986-10-01 Pera Dr. Visnjic Process for obtaining the preparation for the treatment of the disease psoriasis; drug for the treatment of psoriasis and its application
YU46838B (sh) * 1986-02-14 1994-06-24 Pero Dr. Višnjić Postupak za dobijanje preparata za lečenje kožne bolesti psoriazisa
US4780455A (en) * 1985-04-12 1988-10-25 The Trustees Of Columbia University In The City Of New York Lipophilic complexes of pharmacologically active organic compounds
US5002936A (en) * 1985-04-12 1991-03-26 Seymour Lieberman Lipophilic complexes of pharmacologically active inorganic mineral acid esters of organic compounds
US4792556A (en) 1985-09-09 1988-12-20 Syntex (U.S.A.) Inc. Naphthalene anti-psoriatic agents
DE3534743A1 (de) * 1985-09-28 1987-04-02 Beiersdorf Ag Hydrocortisondiester enthaltende o/w-creme
US4740372A (en) * 1986-09-17 1988-04-26 Ljubomir Boncic Composition for treating psoriasis vulgaris and a method for its preparation
US5171737A (en) * 1989-03-03 1992-12-15 The Liposome Company, Inc. Emulsions
US5061700A (en) * 1989-11-16 1991-10-29 Gordon Jay Dow Glyceryl acetate ointment vehicles
DE4234225A1 (de) * 1992-10-10 1994-04-14 Roehm Pharma Gmbh Stabile topische Formulierungen mit gutem Wirkstoff-Freisetzungsvermögen enthaltend mindestens ein lipophilisiertes Makrolidantibiotikum
ES2157996T3 (es) * 1993-10-22 2001-09-01 Smithkline Beecham Corp Nueva composicion.
WO1996002254A1 (en) * 1994-07-15 1996-02-01 Michel Cohen SYNERGISTIC PHARMACEUTICAL COMPOSITONS CONTAINING 16'alpha',17'alpha'-ISOPROPYLIDENEDIOXY SUBSTITUTED PREGNANES
US5707981A (en) * 1994-07-28 1998-01-13 Psorial, L.L.C. Synergistic pharmaceutical compositions
US7179475B1 (en) 1998-12-04 2007-02-20 Johnson & Johnson Consumer Companies, Inc. Anhydrous topical skin preparations
EP1159266B1 (en) 1999-03-05 2004-11-03 Duke University C-16 unsaturated fp-selective prostaglandins analogs
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020146439A1 (en) * 2000-03-31 2002-10-10 Delong Mitchell Anthony Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US6765001B2 (en) * 2001-12-21 2004-07-20 Medicis Pharmaceutical Corporation Compositions and methods for enhancing corticosteroid delivery
US9623000B2 (en) 2008-07-31 2017-04-18 Dekel Pharmaceuticals Ltd Compositions and methods for treating inflammatory disorders
US8623918B2 (en) * 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8722739B2 (en) * 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
JP5833007B2 (ja) 2009-08-31 2015-12-16 ドクター・レディーズ・ラボラトリーズ・リミテッド ステロイドを含む局所製剤
PL2366408T3 (pl) * 2010-03-01 2013-01-31 Salvat Lab Sa Klarowne roztwory wodne acetonidu fluocinolonu do leczenia zapalenia uszu
ES2857602T3 (es) 2014-03-11 2021-09-29 Promius Pharma Llc Composiciones tópicas de corticosteroides
US20160184431A1 (en) 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
PL409156A1 (pl) 2014-08-11 2016-02-15 Matonis Grzegorz Kompozycja kosmetyczna i/lub farmaceutyczna łagodząca objawy łuszczycy
WO2019014299A1 (en) * 2017-07-11 2019-01-17 University Of Miami TOPICAL FORMULATIONS OF ACETAMINOPHENE FOR RELIEF RELIEF
MX2023001259A (es) 2020-07-28 2023-05-15 Arcutis Biotherapeutics Inc Formulaciones tópicas que contienen inhibidor de jak y laureth-4.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3073743A (en) * 1959-07-30 1963-01-15 Upjohn Co Antiinflammatory steroid acetonide compositions and therapy
US3472931A (en) * 1969-01-17 1969-10-14 Foster Milburn Co Percutaneous absorption with lower alkyl amides

Also Published As

Publication number Publication date
CA1067409A (en) 1979-12-04
FI67415B (fi) 1984-11-30
IT1066085B (it) 1985-03-04
BR7600834A (pt) 1976-09-14
AU504748B2 (en) 1979-10-25
JPS6135166B2 (tr) 1986-08-12
IE43655L (en) 1976-08-21
GB1502544A (en) 1978-03-01
DE2605242A1 (de) 1976-09-02
FR2301262A1 (fr) 1976-09-17
FR2301262B1 (tr) 1979-04-06
BE838711A (fr) 1976-08-19
NL7601667A (nl) 1976-08-24
NZ180042A (en) 1978-07-28
AU1068276A (en) 1977-08-04
FI67415C (fi) 1985-03-11
IE43655B1 (en) 1981-04-22
US3934013A (en) 1976-01-20
IL48797A (en) 1979-01-31
ES445151A1 (es) 1977-05-16
JPS51110043A (tr) 1976-09-29
AU1085876A (en) 1977-03-17
FI760344A (tr) 1976-08-22
DK68876A (da) 1976-08-22
IL48797A0 (en) 1976-03-31

Similar Documents

Publication Publication Date Title
ZA7671B (en) Pharmaceutical composition
JPS5272829A (en) Pharmaceutical composition
JPS5265549A (en) Composition
JPS51118844A (en) Nonngreasy composition
EG12289A (en) Microbicial composition
ZA763917B (en) Pharmaceutical compositions and compounds
JPS5218809A (en) Phalmacological composition
HK42382A (en) Pharmaceutical compositions
JPS51112508A (en) Composition
JPS5276389A (en) Galactomannannarylether composition
NZ181503A (en) Substituted diphenyls-ulphides and pharmaceutical compositions
AU1098076A (en) Therapeutic composition
AU1306576A (en) Pharmaceutical formulation
JPS529091A (en) Photoopolymerizable composition
AU1100676A (en) Anti-histomonal composition
AU505476B2 (en) Pharmaceutical composition
JPS5212932A (en) Vermicidal composition
JPS5270398A (en) Dielectriccceramic composition
ZA761012B (en) Pharmaceutical compositions
ZA767215B (en) Pharmaceutical compositions
GB1552416A (en) Pharmaceutical compositions
ZA761880B (en) New pharmaceutical compositions
ZA767193B (en) Pharmaceutical antifertility-combinations
IE43955L (en) Pharmaceutical composition
JPS5276362A (en) Antiifogging composition